A carregar...
Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine
BACKGROUND: This analysis characterizes the immunogenicity profile of galcanezumab, a humanized monoclonal antibody that selectively binds calcitonin gene-related peptide and inhibits its activity, in phase 3 migraine trials. METHODS: Immunogenicity data were analyzed from baseline and double-blind,...
Na minha lista:
| Publicado no: | Cephalalgia |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469706/ https://ncbi.nlm.nih.gov/pubmed/32340471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0333102420920642 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|